Related video above: How patients and doctors can reduce healthcare costs
(NEXSTAR) – While much attention is given to the cost of cars, iPhones, and various consumer products, tariffs introduced by the Trump administration are beginning to increase expenses in a surprising sector – healthcare.
On Monday, Matt McGough from the nonprofit health policy organization KFF reported that multiple insurance companies have already informed state regulators of their plans to raise premiums. This move is intended to mitigate the projected impact of tariffs on pharmaceuticals.
Trump hasn’t yet targeted pharmaceuticals with tariffs, but has repeatedly brought it up, including on Monday aboard Air Force One.
“We’re going to be doing pharmaceuticals very soon,” Trump said, according to Reuters. “That’s going to bring all the companies back, into America.”
In a filing from May, the Independent Health Benefits Corporation (IHBC) announced a proposed premium rate change of 38.4% for 2026. This increase is “mainly attributed to higher costs driven by inflation, tariffs, and modifications in risk adjustment.”
An IHBC spokesperson told Axios that roughly 3% of that increase was to directly account for the impact of tariffs, specifically on drug prices.
McGough notes that there are other insurers who either haven’t specifically mentioned the potential effect of tariffs or who declined to include an offsetting increase in 2026 premium rates.
“A large proportion of medical goods currently comes from international sources, including pharmaceuticals, medical devices and personal protective equipment, as well as other low-margin, high-use essentials like syringes, needles and blood pressure cuffs,” Tina Freese Decker, board chair of the American Hospital Association, wrote in a May post. “Tariffs on these items could impact patient care by jeopardizing the availability of vital medications and essential health care devices. They also could raise costs for hospitals and heighten shortages and supply chain disruptions.”
Meantime, millions of Affordable Care Act (ACA) enrollees could see an over 75% average increase in premiums if Biden-era subsidies aren’t extended by Congress before they expire at the end of the year, according to KFF estimates.
How much tariffs are weighing on the calculations of insurers will become a bit more clear on Aug. 1, Axios notes, when proposed 2026 premium rates are posted.
